Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to a minority of cancer patients. The current priority is to understand why the majority of patients fail to respond. Besides T-cell dysfunction, T-cell apoptosis was reported in several recent studies a...
Prif Awduron: | Zhu, J, Petit, P, Van Den Eynde, B |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Springer Berlin Heidelberg
2018
|
Eitemau Tebyg
-
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
gan: Zhu, J, et al.
Cyhoeddwyd: (2017) -
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
gan: Jeroen F. Vermeulen, et al.
Cyhoeddwyd: (2018-03-01) -
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
gan: Yunyan Dai, et al.
Cyhoeddwyd: (2025-01-01) -
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
gan: Joel Kidman, et al.
Cyhoeddwyd: (2024-12-01) -
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
gan: I.A.J. van Duin, et al.
Cyhoeddwyd: (2024-12-01)